CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
ferric citrate +1 moredrug
Likely dose
ferrous sulfate 325 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02888171
NCT02888171N/ACompleted
CompareCT.gov

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With Moderate to Severe Chronic Kidney Disease (CKD) With Iron Deficiency

University of Alabama at Birmingham·interventional·Posted Sep 2, 2016·Updated Mar 24, 2020

In Brief

A clinical study evaluating ferric citrate and ferrous sulfate for Chronic Kidney Disease and 2 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The main objective of the study is to compare the impact of oral ferric citrate compared to standard of care oral ferrous sulfate on serum iron, percent transferrin saturation, ferritin, hepcidin and hemoglobin levels in individuals with moderate to severe chronic kidney disease (CKD) and absolute iron deficiency.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease, Iron Deficiency, Anemia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2, 2016
Enrollment StartSep 1, 2016
Primary CompletionFeb 12, 2019
Study CompletionMar 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.8 years ago

Interventions

ferric citratedrug

Participants randomized to the ferric citrate arm will take 2 grams of ferric citrate three times a day with meals.

ferrous sulfatedrug

Participants randomized to the ferrous sulfate arm will take 325 mg of ferrous sulfate three times a day.